ArticleTranslational psychiatry2026
Capturing omega sign in the clinical assessment of depression by deep learning.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The omega sign is a melancholic facial expression, resembling the Greek letter omega "Ω". To study static omega sign (visible full-blown Ω-shaped or vertical wrinkles at rest) and dynamic omega sign (newly appearing or deepening) with digital assessment for depression via deep learning, subjects with major depressive disorder (MDD) and controls were invited to take neutral photos and videotaped interviews to study the static and dynamic omega sign, respectively. A deep residual learning model was used to generate automatic prediction. In total, 252 MDD subjects (age: 50.9 ± 11.1 years; 66.7% female) and 192 age- and sex- controlled subjects (age: 49.6 ± 11.7 y; 62.0% female) were recruited. The presence of static omega sign was marginally associated with an increased risk for MDD (MDD subjects: 24.3%, Controls: 16.0%; OR = 1.79, 95% CI = 0.99 to 3.44, P = 0.06). In particular, comorbid MDD and generalized anxiety disorder (GAD) subjects had a significantly higher rate (45.5%) than controls (OR = 6.36, 95% CI = 1.71 to 23.63, P = 0.006). The frequency of dynamic sign was associated with the presence of current moderate to severe depression (OR = 1.04, 95% CI = 1.01 to 1.07, P = 0.02). In summary, MDD patients, especially comorbid with GAD, tended to have a higher rate of static omega sign than controls. The frequency of dynamic sign was associated with an increased risk of having moderate to severe depression. The advance of digital-AI technology offers a novel strategy to provide objective measurement of the omega sign that will assist clinical assessment of depression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.